25 countries in queue for ‘Made in India’ Covid-19 vaccine: Jaishankar

February 6, 2021 0 By boss



India has so far supplied COVID-19 vaccine to 15 countries and another 25 nations are in the queue at different levels for the jab, External Affairs Minister said here on Saturday.


He said there are three categories of countries which are keen to get the vaccine from India- poor, price sensitive nations and other countries which directly deal with pharmaceutical companies that make the antidote.



“I think right now we have already supplied to about 15 countries (as per my recollection).


I would say there would be another about 25 countries which are at different stages in the pipeline. But what it has done is today it has put India on the map of the world,” Jaishankar told reporters in a press conference.


The minister said some poor countries are being supplied the vaccine on a grant basis while some nations wanted it on par with the price that the Indian Government pays to the vaccine makers.


Some countries have directcontractswith the Indian vaccine producing companies and have negotiated commercially, he said.


The Centre has already given the nod for two COVID-19 vaccines– Covaxin of city-based Bharat Biotech and Covishield of Oxford, being manufactured by Serum Institute of India in Pune, which are being administered to frontline workers from January 16, under Emergency Use Authorisation.


Drug maker Dr Reddys recently said it will approach the Drug Regulator for the EUA for Russian vaccine Sputnik V in March.


Jaishankar said Prime Minister Narendra Modis idea was to establish the country as the “Pharmacy of the World”, taking advantage of the domestic capabilities and the way India emerged as IT leader during the Y2K issue.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor





Source link